{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:12:23Z","timestamp":1763017943337,"version":"3.41.2"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s40292-018-0278-8","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T01:19:26Z","timestamp":1537406366000},"page":"327-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Executive Summary of the 2018 Joint Consensus Document on\u00a0Cardiovascular Disease Prevention in Italy"],"prefix":"10.1007","volume":"25","author":[{"name":"the Writing Committee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9642-8380","authenticated-orcid":false,"given":"Massimo","family":"Volpe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the Scientific Societies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allegra","family":"Battistoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Speranza","family":"Rubattu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Tocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"issue":"2 Suppl 1","key":"278_CR1","first-page":"1","volume":"19","author":"M Volpe","year":"2018","unstructured":"Volpe M, Tocci G, Accettura D, Battistoni A, Bellone S, Bellotti P, Bertolotti M, et al. Consensus document and recommendations for the prevention of cardiovascular disease in Italy-2018. G Ital Cardiol. 2018;19(2 Suppl 1):1\u201395.","journal-title":"G Ital Cardiol"},{"key":"278_CR2","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315\u201381.","journal-title":"Eur Heart J"},{"key":"278_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.mayocp.2015.05.001","volume":"90","author":"R Arena","year":"2015","unstructured":"Arena R, Guazzi M, Lianov L, et al. Healthy lifestyle interventions to combat noncommunicable disease\u2014a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine. Mayo Clin Proc. 2015;90:1082\u2013103.","journal-title":"Mayo Clin Proc"},{"key":"278_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.pcad.2016.08.002","volume":"59","author":"M Sagner","year":"2017","unstructured":"Sagner M, McNeil A, Puska P, et al. The P4 health spectrum\u2014a predictive, preventive, personalized and participatory continuum for promoting healthspan. Prog Cardiovasc Dis. 2017;59:506\u201321.","journal-title":"Prog Cardiovasc Dis"},{"unstructured":"Rapporto Osservasalute 2016. Stato di salute e qualit\u00e0 dell\u2019assistenza nelle regioni italiane. http:\/\/www.osservatorio-sullasalute.it\/osservasalute\/rapporto-osservasalute-2016 . Accessed 5 Feb 2018.","key":"278_CR5"},{"unstructured":"Ministero della Salute. Rapporto annuale sull\u2019attivit\u00e0 di ricovero ospedaliero. Dati SDO 2015. Settembre 2016. http:\/\/www.salute.gov.it\/imgs\/C_17_pubblica-zioni_2548_allegato.pdf . Accessed 5 Feb 2018.","key":"278_CR6"},{"key":"278_CR7","first-page":"393","volume":"40","author":"L Palmieri","year":"2004","unstructured":"Palmieri L, Panico S, Vanuzzo D, et al. Gruppo di Ricerca del Progetto CUORE. La valutazione del rischio cardiovascolare globale assoluto: il punteggio individuale del Progetto CUORE. Ann Ist Super Sanita. 2004;40:393\u20139.","journal-title":"Ann Ist Super Sanita"},{"unstructured":"Il Progetto CUORE. Popolazione generale: stili di vita. http:\/\/www.cuore.iss.it\/fattori\/stili.asp . Accessed 5 Feb 2018.","key":"278_CR8"},{"key":"278_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/jhh.2015.4","volume":"29","author":"G Tocci","year":"2015","unstructured":"Tocci G, Ferrucci A, Pontremoli R, et al. Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000\u20132005 and 2005\u20132011 hypertension surveys. J Hum Hypertens. 2015;29:696\u2013701.","journal-title":"J Hum Hypertens"},{"doi-asserted-by":"crossref","unstructured":"Tocci G, Muiesan ML, Parati G, Working Group of the Italian Society of Hypertension(SIIA) and SIIA Foundation, et al. Trends in prevalence, awareness, treatment, and control of blood pressure recorded from 2004 to 2014 during World Hypertension Day in Italy. J Clin Hypertens (Greenwich). 2016;18:551\u2013556.","key":"278_CR10","DOI":"10.1111\/jch.12711"},{"key":"278_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/sj.jhh.1002273","volume":"22","author":"M Volpe","year":"2008","unstructured":"Volpe M, Erhardt LR, Williams B. Managing cardiovascular risk: the need for change. J Hum Hypertens. 2008;22:154\u20137.","journal-title":"J Hum Hypertens"},{"key":"278_CR12","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, et al. 2016 ESC\/EAS Guidelines for the management of dyslipidemias: the Task Force for the Management of Dyslipidemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2999\u20133058.","journal-title":"Eur Heart J"},{"doi-asserted-by":"crossref","unstructured":"Willeit P, Kaptoge S, Welsh P, Natriuretic Peptides Studies Collaboration, et al. Natriuretic peptides and integrated risk assessment for cardiovascular disease: individual-participant-data meta-analysis. Lancet Diabetes Endocrinol. 2016;4:840\u201349.","key":"278_CR13","DOI":"10.1016\/S2213-8587(16)30196-6"},{"key":"278_CR14","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1056\/NEJMra054035","volume":"354","author":"D Mozaffarian","year":"2006","unstructured":"Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans-fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601\u201313.","journal-title":"N Engl J Med"},{"key":"278_CR15","doi-asserted-by":"publisher","first-page":"g4490","DOI":"10.1136\/bmj.g4490","volume":"349","author":"X Wang","year":"2014","unstructured":"Wang X, Ouyang Y, Liu J, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 2014;349:g4490.","journal-title":"BMJ"},{"key":"278_CR16","first-page":"712","volume":"38","author":"G Mancia","year":"2017","unstructured":"Mancia G, Oparil S, Whelton PK, et al. The technical report on sodium intake and cardiovascular disease in low and middle income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association. Eur Heart J. 2017;38:712\u20139.","journal-title":"Eur Heart J"},{"key":"278_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/NEJM200101043440101","volume":"344","author":"FM Sacks","year":"2001","unstructured":"Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3\u201310.","journal-title":"N Engl J Med"},{"key":"278_CR18","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1001\/archinte.166.22.2437","volume":"166","author":"A Castelnuovo Di","year":"2006","unstructured":"Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166:2437\u201345.","journal-title":"Arch Intern Med"},{"key":"278_CR19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","volume":"368","author":"R Estruch","year":"2013","unstructured":"Estruch R, Ros E, Salas-Salvado J, PREDIMED Study Investigators, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279\u201390.","journal-title":"N Engl J Med"},{"key":"278_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/HJR.0b013e328308ba61","volume":"15","author":"A Sanchez-Tainta","year":"2008","unstructured":"Sanchez-Tainta A, Estruch R, Bullo M, PREDIMED Group, et al. Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3204 high-risk patients. Eur J Cardiovasc Prev Rehabil. 2008;15:589\u201393.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"278_CR21","first-page":"126","volume":"100","author":"CJ Caspersen","year":"1985","unstructured":"Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100:126\u201331.","journal-title":"Public Health Rep"},{"key":"278_CR22","volume-title":"Global recommendations on physical activity for health","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Global recommendations on physical activity for health. Geneva: WHO; 2010."},{"key":"278_CR23","first-page":"975","volume":"30","author":"American College of Sports Medicine Position Stand","year":"1998","unstructured":"American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998;30:975\u201391.","journal-title":"Med Sci Sports Exerc"},{"doi-asserted-by":"crossref","unstructured":"European Heart Failure Training Group. Experience from controlled trials of physical training in chronic heart failure: protocol and patients\u2019 factors in effectiveness in the improvement in exercise tolerance. Eur Heart J. 1998;19:466\u201375.","key":"278_CR24","DOI":"10.1053\/euhj.1997.0736"},{"key":"278_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0140-6736(06)69251-9","volume":"368","author":"A Romero-Corral","year":"2006","unstructured":"Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666\u201378.","journal-title":"Lancet"},{"key":"278_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/diacare.27.1.155","volume":"27","author":"JS Torgerson","year":"2004","unstructured":"Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155\u201361.","journal-title":"Diabetes Care"},{"key":"278_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, For the SCALE Obesity and Prediabetes NN8022-1839 Study Group, et al. A randomized, controlled trial of 3.0\u00a0mg of liraglutide in weight management. N Engl J Med. 2015;373:11\u201322.","journal-title":"N Engl J Med"},{"key":"278_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","volume":"376","author":"FL Greenway","year":"2010","unstructured":"Greenway FL, Fujioka K, Plodkowski RA, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double blind, placebo-controlled, phase 3 trial. Lancet. 2010;376:595\u2013605.","journal-title":"Lancet"},{"unstructured":"Societ\u00e0 Italiana di Chirurgia dell\u2019Obesit\u00e0 e delle Malattie Metaboliche. Linee guida di chirurgia dell\u2019obesit\u00e0. Edizione 2016. SICOB. 2016:1\u201382. https:\/\/www.sicob.org\/00_materiali\/linee_guida_2016.pdf . Accessed 5 Feb 2018.","key":"278_CR29"},{"unstructured":"Centers for Disease Control and Prevention; National Center for Chronic Disease Prevention and Health Promotion; Office on Smoking and Health. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. A report of the Surgeon General. Atlanta, GA: CDC; 2010. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK53017 . Accessed 5 Feb 2018.","key":"278_CR30"},{"key":"278_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1056\/NEJM199903253401204","volume":"340","author":"J He","year":"1999","unstructured":"He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease\u2014a meta-analysis of epidemiologic studies. N Engl J Med. 1999;340:920\u20136.","journal-title":"N Engl J Med"},{"doi-asserted-by":"crossref","unstructured":"Rice VH, Stead LF. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2001;(3):CD001188.","key":"278_CR32","DOI":"10.1002\/14651858.CD001188"},{"doi-asserted-by":"crossref","unstructured":"Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;(11):CD000146.","key":"278_CR33","DOI":"10.1002\/14651858.CD000146.pub4"},{"key":"278_CR34","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/archinte.158.11.1197","volume":"158","author":"WC Cushman","year":"1998","unstructured":"Cushman WC, Cutler JA, Hanna E, et al. Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med. 1998;158:1197\u2013207.","journal-title":"Arch Intern Med"},{"key":"278_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/08037050701715117","volume":"16","author":"R Romero","year":"2007","unstructured":"Romero R, Bonet J, de la Sierra A, Aguilera MT, Esopoh Study Investigators. Undiagnosed obesity in hypertension: clinical and therapeutic implications. Blood Press. 2007;16:347\u201353.","journal-title":"Blood Press"},{"key":"278_CR36","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","volume":"42","author":"JE Neter","year":"2003","unstructured":"Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878\u201384.","journal-title":"Hypertension"},{"key":"278_CR37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.pcad.2011.03.006","volume":"53","author":"RH Fagard","year":"2011","unstructured":"Fagard RH. Exercise therapy in hypertensive cardiovascular disease. Prog Cardiovasc Dis. 2011;53:404\u201311.","journal-title":"Prog Cardiovasc Dis"},{"key":"278_CR38","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJM198512123132404","volume":"313","author":"L Rosenberg","year":"1985","unstructured":"Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55\u00a0years of age. N Engl J Med. 1985;313:1511\u20134.","journal-title":"N Engl J Med"},{"key":"278_CR39","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa060838","volume":"354","author":"S Julius","year":"2006","unstructured":"Julius S, Nesbitt SD, Egan BM, Trial of Preventing Hypertension (TROPHY) Study Investigators, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685\u201397.","journal-title":"N Engl J Med"},{"key":"278_CR40","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1097\/HJH.0b013e3282ff8864","volume":"26","author":"S Luders","year":"2008","unstructured":"Luders S, Schrader J, Berger J, PHARAO Study Group, et al. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril inpatients with high-normal blood pressure: a prospective, randomized, controlled prevention- trial of the German Hypertension League. J Hypertens. 2008;26:1487\u201396.","journal-title":"J Hypertens"},{"issue":"27","key":"278_CR41","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1093\/eurheartj\/ehx450","volume":"39","author":"BA Ference","year":"2018","unstructured":"Ference BA, Cannon CP, Landmesser U, L\u00fcscher TF, Catapano AL, Ray KK. Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. Eur Heart J. 2018;39(27):2540\u20135. https:\/\/doi.org\/10.1093\/eurheartj\/ehx450 .","journal-title":"Eur Heart J."},{"key":"278_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.coph.2017.04.005","volume":"33","author":"Y Chang","year":"2017","unstructured":"Chang Y, Robidoux J. Dyslipidemia management update. Curr Opin Pharmacol. 2017;33:47\u201355.","journal-title":"Curr Opin Pharmacol"},{"key":"278_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s40292-017-0211-6","volume":"24","author":"M Volpe","year":"2017","unstructured":"Volpe M, Volpe R, Gallo G, Presta V, Tocci G, Folco E, Peracino A, Tremoli E, Trimarco B. 2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document Italian Society of Cardiovascular Prevention (SIPREC) Writing Committee. High Blood Press Cardiovasc Prev. 2017;24:313\u201329.","journal-title":"High Blood Press Cardiovasc Prev."},{"key":"278_CR44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P Gaede","year":"2003","unstructured":"Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383\u201393.","journal-title":"N Engl J Med"},{"key":"278_CR45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P Gaede","year":"2008","unstructured":"Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580\u201391.","journal-title":"N Engl J Med"},{"key":"278_CR46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa1501352","volume":"373","author":"JB Green","year":"2015","unstructured":"Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR, TECOS Study Group. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373:232\u201342.","journal-title":"N Engl J Med"},{"key":"278_CR47","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","volume":"369","author":"WB White","year":"2013","unstructured":"White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F, EXAMINE Investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013;369:1327\u201335.","journal-title":"N Engl J Med"},{"key":"278_CR48","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"BM Scirica","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I, SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013;369:1317\u201326.","journal-title":"N Engl J Med"},{"key":"278_CR49","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","volume":"366","author":"JA Dormandy","year":"2005","unstructured":"Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lef\u00e8bvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Kor\u00e1nyi L, Laakso M, Mok\u00e1n M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J, PROactive Investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366:1279\u201389.","journal-title":"Lancet"},{"key":"278_CR50","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE, EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117\u201328.","journal-title":"N Engl J Med"},{"issue":"7","key":"278_CR51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"Bruce Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR, CANVAS Program Collaborative Group. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:644\u201357.","journal-title":"New England Journal of Medicine"},{"key":"278_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB, LEADER Steering Committee; LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311\u201322.","journal-title":"N Engl J Med"},{"key":"278_CR53","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsb\u00f8ll T, SUSTAIN-6 Investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834\u201344.","journal-title":"N Engl J Med"},{"key":"278_CR54","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","volume":"377","author":"RR Holman","year":"2017","unstructured":"Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, \u00d6hman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF, EXSCEL Study Group. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2017;377:1228\u201339.","journal-title":"N Engl J Med"},{"issue":"39","key":"278_CR55","first-page":"119","volume":"J2018","author":"B Ibanez","year":"2017","unstructured":"Ibanez B, James S, Agewall S, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology. Eur Heart. 2017;J2018(39):119\u201377.","journal-title":"Eur Heart"},{"key":"278_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267\u2013315.","journal-title":"Eur Heart J"},{"issue":"836\u201345","key":"278_CR57","first-page":"306","volume":"164","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo K. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164(836\u201345):306.","journal-title":"Ann Intern Med"},{"key":"278_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","volume":"9","author":"MJ Thun","year":"2012","unstructured":"Thun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention. Nat Rev Clin Oncol. 2012;9:259\u201367.","journal-title":"Nat Rev Clin Oncol"},{"key":"278_CR59","first-page":"442","volume":"15","author":"M Volpe","year":"2014","unstructured":"Volpe M, Abrignani MG, Borghi C, et al. La terapia con aspirina nella prevenzione cardiovascolare primaria. Documento di consenso intersocietario italiano. G Ital Cardiol. 2014;15:442\u201351.","journal-title":"G Ital Cardiol"},{"unstructured":"Volpe M, Degli Esposti L, Romeo F, et al. Il ruolo dell\u2019aderenza al trattamento farmacologico nella terapia cronica delle malattie cardiovascolari: documento intersocietario di consenso. G Ital Cardiol. 2014;15(10 Suppl 1):3S\u201310S.","key":"278_CR60"},{"unstructured":"Ministero della Salute. Prevenzione e controllo dell\u2019influenza, raccomandazioni per la stagione 2017\u20132018. http:\/\/www.salute.gov.it\/portale\/news\/p3_2_1_1_1.jsp?lingua=italiano&-menu=notizie&p=dalministero&id=3037 . Accessed 5 Feb 2018.","key":"278_CR61"},{"key":"278_CR62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4212\/cjhp.v70i1.1626","volume":"70","author":"MH LeBras","year":"2017","unstructured":"LeBras MH, Barry AR. Influenza vaccination for secondary prevention of cardiovascular events: a systematic review. Can J Hosp Pharm. 2017;70:27\u201334.","journal-title":"Can J Hosp Pharm"},{"key":"278_CR63","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1086\/431521","volume":"192","author":"MH Kyaw","year":"2005","unstructured":"Kyaw MH, Rose CE Jr, Fry AM, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192:377\u201386.","journal-title":"J Infect Dis"},{"key":"278_CR64","doi-asserted-by":"publisher","first-page":"e000247","DOI":"10.1136\/openhrt-2015-000247","volume":"2","author":"S Ren","year":"2015","unstructured":"Ren S, Newby D, Li SC, et al. Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis. Open Heart. 2015;2:e000247.","journal-title":"Open Heart"},{"key":"278_CR65","doi-asserted-by":"publisher","first-page":"e1001048","DOI":"10.1371\/journal.pmed.1001048","volume":"8","author":"VF Corrales-Medina","year":"2011","unstructured":"Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med. 2011;8:e1001048.","journal-title":"PLoS Med"},{"key":"278_CR66","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/21645515.2017.1264834","volume":"13","author":"C Alicino","year":"2017","unstructured":"Alicino C, Trucchi C, Paganino C, et al. Incidence of herpes zoster and post-herpetic neuralgia in Italy: results from a 3-years population-based study. Hum Vaccin Immunother. 2017;13:399\u2013404.","journal-title":"Hum Vaccin Immunother"},{"key":"278_CR67","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/WNL.0b013e3181d31e5c","volume":"74","author":"HC Lin","year":"2010","unstructured":"Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74:792\u20137.","journal-title":"Neurology"},{"key":"278_CR68","doi-asserted-by":"publisher","first-page":"e69156","DOI":"10.1371\/journal.pone.0069156","volume":"8","author":"N Sreenivasan","year":"2013","unstructured":"Sreenivasan N, Basit S, Wohlfarth J, et al. The short- and long-term risk of stroke after herpes zoster\u2014a nationwide population-based cohort study. PLoS One. 2013;8:e69156.","journal-title":"PLoS One"},{"key":"278_CR69","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/WNL.0000000000000038","volume":"82","author":"J Breuer","year":"2014","unstructured":"Breuer J, Pacou M, Gauthier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014;82:206\u201312.","journal-title":"Neurology"},{"key":"278_CR70","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/cid\/ciu098","volume":"58","author":"SM Langan","year":"2014","unstructured":"Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis. 2014;58:1497\u2013503.","journal-title":"Clin Infect Dis"},{"key":"278_CR71","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","volume":"338","author":"GS Berenson","year":"1998","unstructured":"Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650\u20136.","journal-title":"N Engl J Med"},{"key":"278_CR72","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1210\/jc.2007-2458","volume":"93","author":"CP August","year":"2008","unstructured":"August CP, Caprio S, Fennoy I, Endocrine Society, et al. Prevention and treatment of pediatric obesity: an Endocrine Society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab. 2008;93:4576\u201399.","journal-title":"J Clin Endocrinol Metab"},{"unstructured":"Spinelli A, Lamberti A, Nardone P, et al. Sistema di sorveglianza OKkio alla SALUTE: risultati 2010. Roma: Istituto Superiore di Sanit\u00e0; 2012 (Rapporti ISTISAN 12\/14).","key":"278_CR73"},{"issue":"Suppl 5","key":"278_CR74","first-page":"S213","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health, and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute","year":"2011","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health, and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213\u201356.","journal-title":"Pediatrics"},{"key":"278_CR75","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/MPG.0b013e3182169253","volume":"52","author":"C Agostoni","year":"2011","unstructured":"Agostoni C, Braegger C, Decsi T, ESPGHAN Committee on Nutrition, et al. Role of dietary factors and food habits in the development of childhood obesity: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2011;52:662\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"278_CR76","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1471-2431-14-225","volume":"14","author":"GA Kelley","year":"2014","unstructured":"Kelley GA, Kelley KS, Pate RR. Effects of exercise on BMI z-score in overweight and obese children and adolescents: a systematic review with meta-analysis. BMC Pediatr. 2014;14:225.","journal-title":"BMC Pediatr"},{"issue":"1","key":"278_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40292-017-0185-4","volume":"24","author":"Claudio Ferri","year":"2017","unstructured":"Ferri C, et al. Management of Hypertension in the elderly and frail elderly. High Blood Press Cardiovasc Prev. https:\/\/doi.org\/10.1007\/s40292-017-0185-4 .","journal-title":"High Blood Pressure & Cardiovascular Prevention"},{"issue":"6","key":"278_CR78","first-page":"e136","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e136\u20139.","journal-title":"Hypertension."},{"key":"278_CR79","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2016.7050","volume":"315","author":"JD Williamson","year":"2016","unstructured":"Williamson JD, Supiano MA, Applegate WB, SPRINT Research Group, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged\u2009\u2265\u200975\u00a0years: a randomized clinical trial. JAMA. 2016;315:2673\u201382.","journal-title":"JAMA"},{"key":"278_CR80","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/jama.2014.10924","volume":"312","author":"TE Strandberg","year":"2014","unstructured":"Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA. 2014;312:1136\u201344.","journal-title":"JAMA"},{"key":"278_CR81","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40266-017-0448-8","volume":"34","author":"M Bertolotti","year":"2017","unstructured":"Bertolotti M, Franchi C, Rocchi MB, REPOSI Investigators, et al. Prevalence and determinants of the use of lipid-lowering agents in a population of older hospitalized patients: the findings from the REPOSI (REgistro POliterapie Societ\u00e0 Italiana di Medicina Interna) Study. Drugs Aging. 2017;34:311\u20139.","journal-title":"Drugs Aging"},{"key":"278_CR82","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, IMPROVE-IT Investigators, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372:2387\u201397.","journal-title":"N Engl J Med"},{"key":"278_CR83","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/HYPERTENSIONAHA.115.06005","volume":"66","author":"KY Heida","year":"2015","unstructured":"Heida KY, Franx A, van Rijn BB, et al. Earlier age of onset of chronic hypertension and type 2 diabetes mellitus after a hypertensive disorder of pregnancy or gestational diabetes mellitus. Hypertension. 2015;66:1116\u201322.","journal-title":"Hypertension"},{"key":"278_CR84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/hrt.2010.202226","volume":"97","author":"E Kharazmi","year":"2011","unstructured":"Kharazmi E, Dossus L, Rohrmann S, Kaaks R. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart. 2011;97:49\u201354.","journal-title":"Heart"},{"unstructured":"Societ\u00e0 Italiana per la Prevenzione Cardiovascolare(SIPREC). La prevenzione dell\u2019infarto del miocardio nella donna, 2009. http:\/\/www.sciencepromotion.it\/wp-content\/uploads\/2016\/08\/Doc_Prevenzione-infarto-miocardio-donna.pdf . Accessed 5 Feb 2018.","key":"278_CR85"},{"key":"278_CR86","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11739-015-1302-9","volume":"11","author":"KA Meeks","year":"2016","unstructured":"Meeks KA, Freitas-Da-Silva D, Adeyemo A, et al. Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis. Intern Emerg Med. 2016;11:327\u201340.","journal-title":"Intern Emerg Med"},{"key":"278_CR87","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.diabres.2017.05.023","volume":"130","author":"PA Modesti","year":"2017","unstructured":"Modesti PA, Castellani S, Calabrese M, Malandrino D, Zhao D. Comparison of type 2 diabetes prevalence in Chinese migrants vs Caucasians and new perspectives for screening of cerebrovascular disease in Chinese: a proof of concept study. Diabetes Res Clin Pract. 2017;130:196\u2013203.","journal-title":"Diabetes Res Clin Pract"},{"key":"278_CR88","first-page":"357","volume":"38","author":"PA Modesti","year":"2014","unstructured":"Modesti PA, Han Y, Jing Y, et al. Disegno e modalit\u00e0 di realizzazione dello studio CHIP (CHinese In Prato). Epidemiol Prev. 2014;38:357\u201363.","journal-title":"Epidemiol Prev"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-018-0278-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T22:51:08Z","timestamp":1751928668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-018-0278-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1007\/s40292-018-0278-8","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"type":"print","value":"1120-9879"},{"type":"electronic","value":"1179-1985"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"1 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Authors have no conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain data derived by any current studies with human participants performed by any of the authors. The clinical studies mentioned were provided with specific ethical approval.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}